Prevention of Hepatitis B in Surgeons and Their Patients

Abstract

Get full access to this article

View all access options for this article.

References

Hepatitis B vaccine. Med Lett 24:75, 1982.

Szmuness W. , et al. Hepatitis B vaccine. Demonstration of efficacy in a controlled trial in a high-risk population in the United States. N Engl J Med 303:833, 1980.

Francis DP , et al. The prevention of hepatitis B with vaccine. Ann Intern Med 97:362, 1982.

Mulley AG , Silverstein MD , Dienstag JL Indications for use of hepatitis B vaccine, based on cost-effective analysis . N Engl J Med 307:644, 1982.

Recommendation of the Immunization Practices Advisory Committee, Centers for Disease Control. Inactivated hepatitis B virus vaccine. Ann Intern Med 97:379, 1982.

Recommendation of the Immunization Practices Advisory Committee, Centers for Disease Control. Recommendations for protection against viral hepatitis. Ann Intern Med 103:391, 1985.

Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control. Update on hepatitis B prevention. Ann Intern Med 107:353, 1987.

Centers for Disease Control. Hepatitis Surveillance Report No. 50. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 1986 .

Anderson AC , Hodges GR Acceptance of hepatitis B vaccine among high-risk health care workers . Am J Infect Control 11:207, 1983.

10.

Klimek JJ , et al. A multi-hospital hepatitis B vaccine program: Prevalence of antibody and acceptance of vaccination among high-risk hospital employees . Infect Control 6:32, 1985.

11.

Crossley KB , Gerding DN , Petael RA Acceptance of hepatitis B vaccine by hospital personnel. Infect Control 6:147, 1985.

12.

Bodenheimer HC , Fulton JP , Kramer PD Acceptance of hepatitis B vaccine among hospital workers. Am J Public Health 76:252, 1986.

13.

Fulton JP , Bodenheimer HC , Kramer PD Acceptance of hepatitis B vaccine among hospital workers: A follow-up . Am J Public Health 76:1339, 1986.

14.

Denes AE , et al. Hepatitis B infection in physicians: Results of a nationwide seroepidemiologic survey JAMA 239:210, 1978.

15.

Dienstag JL , Ryan DM

Occupational exposure to hepatitis B virus in hospital personnel: Infection or immunization?

Am J Epidemiol 115:26, 1982.

16.

Palmer DL , et al. Hepatitis among hospital employees. West J Med 138:519, 1983.

17.

Maynard JE Nosocomial viral hepatitis. Am J Med 70:439, 1981.

18.

Smith JL , et al. Comparative risk of hepatitis B among physicians and dentists . J Infect Dis 133:705, 1976.

19.

Steinbuch M. , Gaeuman JV Risk of hepatitis B in hospital personnel. J Occup Med 28:276, 1986.

20.

Guillen-Solvas J. , et al. The risk of infection with hepatitis B virus in relation to length of hospital employment. J Hosp Infect 9:43, 1987.

21.

Mayor GH , et al. Prevalence of hepatitis B in 27 Michigan hemodialysis centers . Am J Public Health 69:581, 1979.

22.

Koplan JP , et al. Prevalence of hepatitis B surface antigen and antibody in a state prison in Kansas. J Infect Dis 137:505, 1978.

23.

Luzzio AJ , et al. Prevalence of Australia antigen in military populations. Milit Med 140:41, 1975.

24.

Schreeder MT , et al. Epidemiology of hepatitis B in gay men . J Homosex 5:307, 1980.

25.

Barrett DH , et al. Epidemiology of hepatitis B in two Alaskan communities. Am J Epidemiol 105:118, 1977.

26.

Chaudhary RK , Nicholls ES , Kennedy DA Prevalence of hepatitis B markers in Indochinese refugees. Can Med Assoc 125:1243, 1981.

27.

Harris JR , et al. The low risk of hepatitis in rural hospitals: Results of a seroepidemiologic survey JAMA 252:3270, 1984.

28.

Hicks CG , Hargiss CD , Harris JR Prevalence survey for hepatitis B in high-risk university hospital employees . Am J Infect Control 13:1, 1985.

29.

Snyman DR , et al. Nosocomial viral hepatitis B: A cluster among staff with subsequent transmission to patients. Ann Intern Med 85:573, 1976.

30.

Report of a Collaborative Study by the Communicable Disease Surveillance Center and the Epidemiological Research Laboratory of the Public Health Laboratory Service with a District Control-of-Infection Service: Acute hepatitis B associated with gynecological surgery. Lancet 1:1, 1980.

31.

LaBrecque DR , et al. The risk of hepatitis B transmission from health care workers to patients in a hospital setting. Hepatology 6:205, 1986.

32.

Tiollais P. , Pourcel C. , Dejean A. The hepatitis B virus . Nature 317:489, 1985.

33.

Summers J. The recently described animal virus models for human hepatitis B virus . Hepatology 1:179, 1981.

34.

Tiollais P. , Charnay P. , Vyas GN Biology of hepatitis B virus. Science 213:406, 1981.

35.

Neurath AR , et al. Hepatitis B virus contains pre-S gene-encoded domains. Nature 315:154, 1985.

36.

Hoofnagle JH , et al. Serologic responses in hepatitis B. In Vyas GN , Cohen SN , Schmid R , editors. Viral Hepatitis. Philadelphia: Franklin Institute Press , 1978, pp 219-242.

37.

Hoofnagle JH , Schafer DF Serologic markers of hepatitis B virus infection . Semin Liver Dis 6:1, 1986.

38.

Chau KH , et al. Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc . Hepatology 3:142, 1983.

39.

Krogsgaard K. , et al. Hepatitis B virus DNA in serum from patients with acute hepatitis B. Hepatology 5:10, 1985.

40.

Linday KL , Redeker AG , Ashcavai M. Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1:586, 1981.

41.

Hoofnagle JH , Alter JH Chronic viral hepatitis. In Vyas GN , Dienstag JL , Hoofnagle JH , eds. Viral Hepatitis and Liver Disease. New York: Grune & Stratton, 1984, pp 97-113.

42.

Pontisso P. , et al. Relationship between HBcAg in serum and liver and HBV replication in patients with HBsAg-positive chronic liver disease. J Med Virol 17:145, 1985.

43.

Recombinant hepatitis B vaccine. Med Lett 28:118, 1986.

44.

Szmuness W. , et al. Hepatitis B vaccine in medical staff of hemodialysis units: Efficacy and subtype cross-protection. N Engl J Med 307:1481, 1982.

45.

Stevens CE , et al. Perinatal hepatitis B virus transmission in the United States . JAMA 253:1740, 1985.

46.

Stevens CE , et al. Safety of the hepatitis B vaccine. N Engl J Med 312: 375, 1985.

47.

Centers for Disease Control. Hepatitis B vaccine: Evidence confirming lack of AIDS transmission. MMWR 33:685, 1984.

48.

Francis DP , et al. The safety of hepatitis B vaccine: Inactivation of the AIDS virus during routine vaccine manufacture. JAMA 256:869, 1986.

49.

Stevens CE , Taylor PE Hepatitis B vaccine: Issues, recommendations and new developments . Semin Liver Dis 6:23, 1986.

50.

Stevens CE , et al. Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy. N Engl J Med 311:496, 1984.

51.

Weitberg AB , et al. Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy J Clin Oncol 3:718, 1985.

52.

Scolnick EM , et al. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA 251:2812, 1984.

53.

Davidson M. , Krugman S. Immunogenicity of recombinant yeast hepatitis B vaccine. Lancet 1:108,1985.

54.

Hollinger FB , et al. Anti-HBs responses to vaccination with a human hepatitis B vaccine made by recombinant DNA technology in yeast. J Infect Dis 153:156, 1986.

55.

Stevens CE , et al. Yeast recombinant hepatitis B vaccine: Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission . JAMA 257:2612, 1987.

56.

Genetically engineered hepatitis B vaccine guidelines-corrections. Calif Morbidity No. 10, 1987.